Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butantan-DV Phase 3 Trial
NCT02406729Phase 3Active, not recruiting
- Sponsor
- Instituto Butantan
- Start
- Feb 2016
- Primary completion
- Jul 2021
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Butantan-DV in dengue fever, sponsored by Instituto Butantan. Started Feb 2016; status: active, not recruiting.
02
Drugs
Butantan-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT02406729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02406729.